Suchergebnisse - "Inoubli, Adrien"

PubPharm (10)

1

Authors' Reply to Braillon and Martin's Comment on "Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)"

enthalten in: Drug safety | 2021

von Bahri, P. | Morales, D. | Inoubli, A. | +2

CommentOn: Drug Saf. 2021 Feb;44(2):193-209. - PMID 33125664

2

Authors’ Reply to Braillon and Martin’s Comment on “Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)”

enthalten in: Drug safety | 2021

von Bahri, P. | Morales, D. | Inoubli, A. | +2

3

Authors’ Reply to Braillon and Martin’s Comment on “Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)”

enthalten in: Drug safety | 2021

von Bahri, P. | Morales, D. | Inoubli, A. | +2

4

Authors’ Reply to Braillon and Martin’s Comment on “Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)”

enthalten in: Drug safety | 2021

von Bahri, P. | Morales, D. | Inoubli, A. | +2

5

Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)

enthalten in: Drug safety | 2021

von Bahri, P. | Morales, D. | Inoubli, A. | +2

CommentIn: Drug Saf. 2021 Sep;44(9):1011-1013. - PMID 34324172

6

Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)

enthalten in: Drug safety | 2020

von Bahri, P. | Morales, D. | Inoubli, A. | +2

7

Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)

enthalten in: Drug safety | 2020

von Bahri, P. | Morales, D. | Inoubli, A. | +2

8

Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)

enthalten in: Drug safety | 2020

von Bahri, P. | Morales, D. | Inoubli, A. | +2

9

Karyotyping, is it worthwhile in transsexualism?

enthalten in: The journal of sexual medicine | 2011

von Inoubli, A. | De Cuypere, G. | Rubens, R. | +5

10

Karyotyping, Is It Worthwhile in Transsexualism?

enthalten in: The journal of sexual medicine | 2011

von Inoubli, A. | De Cuypere, G. | Rubens, R. | +5

1
[1]